SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TransMedics Group
If you suffered losses exceeding $50,000 in TransMedics between February 23, 2023 and January 10, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at ...
TMDX INVESTOR ALERT: TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
CASE ALLEGATIONS: TransMedics is a commercial-stage medical technology company that engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and ...
TMDX Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against TransMedics Group, Inc. (TMDX)
The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that a securities class action lawsuit has been filed against TransMedics Group, Inc. (“TransMedics”) ( NASDAQ: TMDX) on behalf ...
TransMedics Group (TMDX) Slid as Results Fell Short of Expectations
Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” fourth-quarter 2024 ...
Le Lézard2d
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against TransMedics Group, Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that a securities class action lawsuit has been filed against TransMedics Group, Inc. ("TransMedics") on behalf of those who ...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims On Behalf Of Investors Of Transmedics Group
If you purchased or acquired securities in TransMedics between February 23, 2023 and January 10, 2025 and would like to ...
Le Lézard5d
Shareholders that lost money on TransMedics Group, Inc.(TMDX) should contact The Gross Law Firm about pending Class Action - TMDX
The Gross Law Firm issues the following notice to shareholders of TransMedics Group, Inc. . Shareholders who purchased shares of ...
Canaccord Genuity Group Reiterates “Buy” Rating for TransMedics Group (NASDAQ:TMDX)
TransMedics Group (NASDAQ:TMDX – Get Free Report)‘s stock had its “buy” rating restated by Canaccord Genuity Group in a ...
Down 62%. Should You Buy TransMedics Stock on the Dip?
Outside of the U.S., where OrganOx has a larger footprint, livers account for about 1% of TransMedics Group's sales. If ...
TMDX CLASS ACTION ALERT: Transmedics Group, Inc. Is Being Sued In Connection With Its Business Practices – Contact Robbins LLP For Information
On this news, the price of TransMedics stock fell $3.74 per share, or 5.15%, to close at $68.81 on January 10, 2025. On January 13, 2025, TransMedics stock fell a further $4.76 per share, or 6.9%, to ...
The Bakersfield Californian11d
TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ Trafficking – Hagens Berman
A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX), a medical technology company specializing in organ transplant therapy, alleging ...
AHA/ASA Journals11d
Clinical Outcomes With Normothermic Pulsatile Organ Perfusion in Heart Transplantation: A Report From the OCS Heart Perfusion Registry
BACKGROUND: A preservation system, the Organ Care System (OCS; TransMedics) uses normothermic pulsatile perfusion during organ transport for heart transplantation. This system has demonstrated ...